Long‐term (up to 18 years) effects on GH/IGF‐1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH‐secreting pituitary adenoma responsive to SSTaJean Christophe Maiza, Philippe Caron, F. Loubes-Lacroix et al.|Clinical Endocrinology|2007Cited by 121
Increased plasma β-hydroxybutyrate levels during the fasting test in patients with endogenous hyperinsulinaemic hypoglycaemiaAlexandre Buffet, Philippe Caron, Delphine Vezzosi et al.|European Journal of Endocrinology|2013Cited by 15